Our next webinar will be discussing the latest research news surrounding gene therapies for #Parkinsons on 4 September at 5pm BST, presented in partnership with Journal of Parkinson's Disease and chaired by Professor Tilo Kunath from The University of Edinburgh. Book your free tickets: buff.ly/4cuFVdu

Our committee is unable to recommend lecanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer’s disease. Benefits of slowing disease progression, by 4-6 months on average, can not justify the high cost to the NHS. Learn more: nice.org.uk/news/articles/…

Debate rages over Alzheimer’s drug lecanemab as UK limits approval. Nature - at least this article gets a range of opinions to characterise the debate we are having. nature.com/articles/d4158…

Join the Edinburgh #Parkinsons Lecture on 17th September and learn from Richelle Flanagan 💚💚💚💚 how nutrition and diet can help you live better with Parkinson's. Free registration to watch in-person or online: eu1.hubs.ly/H0bWFP70

Cognitive impairment: is it due to multiple sclerosis or Alzheimer's disease? I have always assumed that people with multiple sclerosis are protected from getting Alzheimer's disease. Why? Or have I got it wrong? => buff.ly/3yTG9go

Open position alert! Collaboration btw ourselves, AnnaWilliamsLab and Biogen on demyelination and neurodegeneration. Candidates with expertise in RNAseq and/or use of zebrafish for molecular studies particularly welcome. Link to posting (do share!): elxw.fa.em3.oraclecloud.com/hcmUI/Candidat…

Come and work in the best Geriatric Medicine Department in the most gorgeous city! We are looking for a new colleague to join our team GeriatricMedWGH at the Western General Hospital, Edinburgh. apply.jobs.scot.nhs.uk/Job/JobDetail?… RCPEdin Trainees British Geriatrics Society

📢 Final virtual places for #Parkinsons Foundation MasterClass 47! This two-day course will give you a solid grounding in the knowledge and skills you need to practice in this clinical area. 🗓️ 24th - 25th September 2024 Apply now: eu1.hubs.ly/H0bYNdQ0

I cannot wait to see this documentary. Impact of #Parkinson is devastating, and the challenges of living with this progressive neurodegenerative disorder in Tanzania & other parts of Africa are enormous. I am determined to work with local neurologists to see how we can offer help

Significant organisational changes are required to ensure a successful implementation of a vocational rehabilitation intervention within current NHS services.

✍️ Just 1 week to go until our next Journal Webinar on #MultipleSclerosis! Don't miss out on this opportunity to enhance your knowledge! 🗓️ 4 Sept, 15:00 - 16:00 CEST 🔗 Register now (EAN members only): ean.org/learn/elearnin… #Neurology #NeuroX European Academy of Neurology Wiley Neuro

Important discovery: Multiple sclerosis patients exhibit reduced amyloid-beta accumulation, which is a key pathological feature of Alzheimer’s disease. I wonder if this could be explained by the loss of oligodendrocytes, which we recently found can produce and release

In case you missed it: groundbreaking #research in Scotland is using Artificial Intelligence (AI) to analyse 1.6 million brain scans to identify patterns that could help predict the risk of #dementia. Read more: bbc.co.uk/news/articles/…

Patients with Parkinson’s are at risk of significant harm if they don’t get their medication on time, every time. Help us spread the message by sharing our patient stories in education sessions with your colleagues 📢⏱️💊 Listen to Barrie's full story: bit.ly/3WEXzW0

The #PalliativeCare MasterClass challenges the accepted thoughts around palliative care as an #endoflife service and offers practical ideas and group discussions for collaborative approaches to exceptional care in #neurology. 🗓️ 12-13th November 2024 eu1.hubs.ly/H0c0zGk0

We know that pesticides and other chemicals can increase the risk of #Parkinson Disease. They can also interact with genetic risks, which might explain some of the clusters we see in these rural communities. Hopefully, can we do more to reduce this risk abc.net.au/news/2024-08-3…

Press Release: HERCULES study demonstrates Tolebrutinib successfully delays disability in non-relapsing secondary progressive MS!

🚀 Only 2 weeks until #ECTRIMS2024 in Copenhagen! Join us as we celebrate 40 years of advancements in MS research with keynotes from top experts & more! 💻 Can’t make it in person? Join us online! Register now 👉 bit.ly/3M7PhRz #MS #MultipleSclerosis #MSResearch

How might AI help us to detect dementia through retinal scans? 👀 As part of #WorldAlzheimersMonth, we spoke to Professor Pearse Keane, @UCLEye about pioneering studies in the emerging field of #oculomics ➡️ bit.ly/3XuReOH Moorfields Eye Hospital NHS Foundation Trust @INSIGHTEyeHub #UCLDementia